These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 38239356)

  • 21. Targeted therapy of kidney disease with nanoparticle drug delivery materials.
    Shang S; Li X; Wang H; Zhou Y; Pang K; Li P; Liu X; Zhang M; Li W; Li Q; Chen X
    Bioact Mater; 2024 Jul; 37():206-221. PubMed ID: 38560369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemotherapeutic potential of PEG-b-PLGA copolymer micelles that combine chloroquine as autophagy inhibitor and docetaxel as an anti-cancer drug.
    Zhang X; Zeng X; Liang X; Yang Y; Li X; Chen H; Huang L; Mei L; Feng SS
    Biomaterials; 2014 Nov; 35(33):9144-54. PubMed ID: 25109439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomaterials and autophagy: new insights in cancer treatment.
    Panzarini E; Inguscio V; Tenuzzo BA; Carata E; Dini L
    Cancers (Basel); 2013 Mar; 5(1):296-319. PubMed ID: 24216709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
    Ozeki T; Tagami T
    Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment.
    Cordani M; Somoza Á
    Cell Mol Life Sci; 2019 Apr; 76(7):1215-1242. PubMed ID: 30483817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomedicine-nanoscale drugs and delivery systems.
    Singh S
    J Nanosci Nanotechnol; 2010 Dec; 10(12):7906-18. PubMed ID: 21121278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicology of nanomaterials used in nanomedicine.
    Zhao J; Castranova V
    J Toxicol Environ Health B Crit Rev; 2011; 14(8):593-632. PubMed ID: 22008094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer drug delivery in the nano era: An overview and perspectives (Review).
    Li Z; Tan S; Li S; Shen Q; Wang K
    Oncol Rep; 2017 Aug; 38(2):611-624. PubMed ID: 28627697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH-Sensitive Polymeric Nanoparticles with Gold(I) Compound Payloads Synergistically Induce Cancer Cell Death through Modulation of Autophagy.
    Lin YX; Gao YJ; Wang Y; Qiao ZY; Fan G; Qiao SL; Zhang RX; Wang L; Wang H
    Mol Pharm; 2015 Aug; 12(8):2869-78. PubMed ID: 26101892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomedicine for Cancer Therapy Using Autophagy: An Overview.
    Kotcherlakota R; Rahaman ST; Patra CR
    Curr Top Med Chem; 2018; 18(30):2599-2613. PubMed ID: 30582477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention.
    Rao J; Mei L; Liu J; Tang X; Yin S; Xia C; Wei J; Wan D; Wang X; Wang Y; Li M; Zhang Z; He Q
    Acta Biomater; 2019 Apr; 89():300-312. PubMed ID: 30878446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbon Nanomaterials: Efficacy and Safety for Nanomedicine.
    Yamashita T; Yamashita K; Nabeshi H; Yoshikawa T; Yoshioka Y; Tsunoda SI; Tsutsumi Y
    Materials (Basel); 2012 Feb; 5(2):350-363. PubMed ID: 28817050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spotlight on Photoactivatable Liposomes beyond Drug Delivery: An Enabler of Multitargeting of Molecular Pathways.
    Saad MA; Hasan T
    Bioconjug Chem; 2022 Nov; 33(11):2041-2064. PubMed ID: 36197738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical and dental applications of nanomedicines.
    Kavoosi F; Modaresi F; Sanaei M; Rezaei Z
    APMIS; 2018 Oct; 126(10):795-803. PubMed ID: 30264432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elastin-like polypeptide-based micelles as a promising platform in nanomedicine.
    van Strien J; Escalona-Rayo O; Jiskoot W; Slütter B; Kros A
    J Control Release; 2023 Jan; 353():713-726. PubMed ID: 36526018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis.
    Taheriazam A; Abad GGY; Hajimazdarany S; Imani MH; Ziaolhagh S; Zandieh MA; Bayanzadeh SD; Mirzaei S; Hamblin MR; Entezari M; Aref AR; Zarrabi A; Ertas YN; Ren J; Rajabi R; Paskeh MDA; Hashemi M; Hushmandi K
    J Control Release; 2023 Feb; 354():503-522. PubMed ID: 36641122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs.
    Raza F; Siyu L; Zafar H; Kamal Z; Zheng B; Su J; Qiu M
    Curr Pharm Des; 2022; 28(5):380-394. PubMed ID: 34727851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review.
    Jin C; Wang K; Oppong-Gyebi A; Hu J
    Int J Med Sci; 2020; 17(18):2964-2973. PubMed ID: 33173417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.